Wells Fargo Maintains Overweight on Humana, Raises Price Target to $602
Wells Fargo analyst Stephen Baxter maintains Humana (NYSE:HUM) with a Overweight and raises the price target from $502 to $602.
Last updated: 2026-11-14 17:11:00. Prices reflect the latest closing data and will resume updating on the next trading day. Stock price data is sourced from Massive.
Humana Inc. (HUM) operates in the HOSPITAL & MEDICAL SERVICE PLANS sector and is listed on NYSE. The stock is currently priced at $450.28, with a market capitalization of $53.29B and a P/E ratio of 41.66. Over the past 52 weeks, its price has ranged from $163.11 to $456.50. This page covers its latest market performance, valuation, price trends and company information.
$53.29B | |
$445.69 | |
$450.69 | |
$435.59 | |
$443.68 | |
1.08M | |
1.36M | |
41.66 | |
$456.50 | |
$163.11 | |
0.81% | |
-- |
Humana Inc. (HUM) last closed at $450.28 as of 2026-11-14 01:01:00, up 1.42% ($6.32) from the previous close of $443.68.
During the latest regular trading session, HUM traded between $435.59 and $450.69, with a volume of 1.08M shares. The closing price was near the upper end and near the upper end of its 52-week range.
Over the past seven days, Humana Inc. (HUM) moved from $411.79 to $450.28, representing a gain of 9.35% ($38.49).
The stock traded between $405.40 and $451.04 during the period. The latest price is near the upper end of the 7-day range, indicating strong upward.
The average daily volume was 2.06 million shares, up versus the previous seven-day period, indicating higher trading activity.
Position in Range: 97.9%
HUM is currently trading at $450.28, placing it 97.9% of the way from its 52-week low of $163.11 to its 52-week high of $456.50. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
Humana is one of the largest private health insurers in the US, and the firm has built a niche specializing in government-sponsored programs, with nearly all its medical membership stemming from Medicare, Medicaid, and the military's Tricare program. Beyond medical insurance, the company provides other healthcare services, including primary-care services, at-home services, and pharmacy benefit management.
| Industry | HOSPITAL & MEDICAL SERVICE PLANS |
| Employees | 67,060 |
| Exchange | NYSE |
| Company Website |
View the latest dividend and stock split events for Humana Inc.
Dividend | |
|---|---|
| Ex-Dividend Date | Dec 24, 2026 |
| Payment Date | Jan 29, 2027 |
| Dividend Per Share | $0.885 |
Latest news related to Humana Inc. and HUM stock.
Wells Fargo analyst Stephen Baxter maintains Humana (NYSE:HUM) with a Overweight and raises the price target from $502 to $602.
Humana Inc. has launched a new oncology care model in partnership with Evolent Health and American Oncology Network across eight states. The initiative streamlines prior authorization for qualifying practices, uses EHR analytics and provider scorecards to promote evidence-based cancer treatment, and aims to improve care coordination while reducing specialty care spending. HUM stock has rallied 82.2% over the past year but trades at a premium valuation of 29.08x forward P/E versus the industry average of 15.72x.
Humana (HUM) has been upgraded to Zacks Rank #1 (Strong Buy) due to upward revisions in earnings estimates. The company is expected to earn $9.36 per share for fiscal year 2026, with consensus estimates rising 4.9% over the past three months. The upgrade positions Humana in the top 5% of Zacks-covered stocks, suggesting potential for near-term stock price appreciation driven by improving business fundamentals.
Eligible investors can buy real shares of Humana Inc. (HUM) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.
Stock prices and market data on this page, including price changes and market status, are provided by Massive and other third-party news and data platforms. Market data may be delayed and may differ from prices on other platforms or the prices at which trades are executed on MEXC. MEXC does not guarantee the accuracy, completeness, or timeliness of third-party data. MEXC offers trading products related to HUM, including Stocks, Tokenized Stocks, and Stock Futures.
The stock price information displayed on this page is provided for reference purposes only and may be delayed or differ from real-time market data. Prices, charts, and related metrics do not constitute investment advice and should not be relied upon for trading or investment decisions. MEXC is not responsible for any losses incurred based on the stock price information provided on this page. Please refer to official market sources or consult licensed financial professionals before making any investment decisions.
Estimate the value between HUM shares and USD.
HUM Shares to USD
1.00 HUM shares = 450.28 USD
Calculations are estimates based on the latest available price and are for reference only.